Cem Çöteli1, Muhammet Dural2, Yusuf Ziya Şener3, Ahmet Hakan Ateş3, Metin Okşul3, Mert Ruşen Gülşen4, Fahrünisa Meryem Betül Erol4, Burak Sezenöz5, Hikmet Yorgun3, Kudret Aytemir3. 1. Department of Cardiology, Ankara City Hospital, Ankara, Turkey. 2. Department of Cardiology, Eskişehir Osmangazi University School of Medicine, 26040, Odunpazari, Eskisehir, Turkey. muhammet_dural@hotmail.com. 3. Arrhythmia and Electrophysiology Unit, Department of Cardiology, Hacettepe University School of Medicine, Ankara, Turkey. 4. Hacettepe University School of Medicine, Ankara, Turkey. 5. Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Abstract
PURPOSE: Cryoballoon (CB) and radiofrequency (RF) ablation techniques have similar outcomes for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). However, there is limited data about the impact of different ablation strategies in patients with left common pulmonary vein (LCPV). Our aim was to compare the safety and efficacy of RF and CB ablation in AF patients with LCPV. METHODS: One hundred and twenty-seven (n = 80 CB and n = 47 RF) AF patients with LCPV detected by preprocedural computerized tomography (CT) were included in the study. Ostial dimensions and trunk distance were measured in all patients. Atrial tachyarrhythmia (ATa) recurrence was defined as detection of AF, atrial flutter, or atrial tachycardia (≥ 30 s) after a 3-month blanking period. RESULTS: There was no significant difference in acute procedural success rates for PVI (97.5% in CB and 97.9% in RF, respectively, P = 0.953) and complication rates were similar between the groups (6 (7.5%) in CB and 4 (8.5%) in RF, respectively, P = 1.000). During a median follow-up of 20.7 (4.8-50.2) months for CB and 20.5 (6.2-36.0) months for RF, ATa recurrence was 35.0% and 38.2%, respectively (P = 0.777). Multivariate analysis did not reveal any of the morphologic parameters of LCPV as a significant predictor of ATa recurrence. CONCLUSIONS: Our findings demonstrated that both CB and RF ablation techniques have similar efficacy and safety in AF patients with LCPV during the mid-term follow-up.
PURPOSE: Cryoballoon (CB) and radiofrequency (RF) ablation techniques have similar outcomes for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). However, there is limited data about the impact of different ablation strategies in patients with left common pulmonary vein (LCPV). Our aim was to compare the safety and efficacy of RF and CB ablation in AF patients with LCPV. METHODS: One hundred and twenty-seven (n = 80 CB and n = 47 RF) AF patients with LCPV detected by preprocedural computerized tomography (CT) were included in the study. Ostial dimensions and trunk distance were measured in all patients. Atrial tachyarrhythmia (ATa) recurrence was defined as detection of AF, atrial flutter, or atrial tachycardia (≥ 30 s) after a 3-month blanking period. RESULTS: There was no significant difference in acute procedural success rates for PVI (97.5% in CB and 97.9% in RF, respectively, P = 0.953) and complication rates were similar between the groups (6 (7.5%) in CB and 4 (8.5%) in RF, respectively, P = 1.000). During a median follow-up of 20.7 (4.8-50.2) months for CB and 20.5 (6.2-36.0) months for RF, ATa recurrence was 35.0% and 38.2%, respectively (P = 0.777). Multivariate analysis did not reveal any of the morphologic parameters of LCPV as a significant predictor of ATa recurrence. CONCLUSIONS: Our findings demonstrated that both CB and RF ablation techniques have similar efficacy and safety in AF patients with LCPV during the mid-term follow-up.
Authors: Alexey Tsyganov; Jan Petru; Jan Skoda; Lucie Sediva; Pavel Hala; Jiri Weichet; Marek Janotka; Milan Chovanec; Petr Neuzil; Vivek Y Reddy Journal: J Interv Card Electrophysiol Date: 2015-10-16 Impact factor: 1.900
Authors: Martin Schmidt; Uwe Dorwarth; Florian Straube; Marcos Daccarett; Johannes Rieber; Michael Wankerl; Jürgen Krieg; Alexander W Leber; Ullrich Ebersberger; Armin Huber; Ernst Rummeny; Ellen Hoffmann Journal: Int J Cardiol Date: 2011-12-27 Impact factor: 4.164
Authors: Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo Journal: N Engl J Med Date: 2016-04-04 Impact factor: 91.245
Authors: Sven Knecht; Michael Kühne; David Altmann; Peter Ammann; Beat Schaer; Stefan Osswald; Christian Sticherling Journal: J Cardiovasc Electrophysiol Date: 2012-11-06
Authors: Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins Journal: Eur Heart J Date: 2021-02-01 Impact factor: 29.983